Federated Hermes, Inc. Revance Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 9 shares of RVNC stock, worth $23. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 2,237,505 100.0%

Holding current value

$23

Previous $5.75 Million 100.0%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.57 - $2.57 $5.75 Million - $5.75 Million	-2,237,496 Reduced 100.0%	9 $0
Q2 2024 Aug 08, 2024	BUY	$2.34 - $4.73 $1.57 Million - $3.18 Million	672,803 Added 43.0%	2,237,505 $5.75 Million
Q1 2024 May 14, 2024	BUY	$4.65 - $9.31 $6.89 Million - $13.8 Million	1,482,525 Added 1804.06%	1,564,702 $7.7 Million
Q4 2023 Jan 31, 2024	BUY	$5.81 - $11.2 $252,090 - $485,956	43,389 Added 111.86%	82,177 $722,000
Q3 2023 Nov 13, 2023	BUY	$11.47 - $25.07 $370,997 - $810,889	32,345 Added 502.02%	38,788 $444,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $159,142 - $242,321	6,443 New	6,443 $163,000
Q4 2022 Feb 13, 2023	SELL	$18.32 - $30.66 $1.1 Million - $1.83 Million	-59,844 Reduced 62.24%	36,302 $670,000
Q3 2022 Nov 14, 2022	SELL	$14.33 - $28.47 $361,889 - $718,981	-25,254 Reduced 20.8%	96,146 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $433,036 - $766,836	37,590 Added 44.85%	121,400 $1.68 Million
Q3 2018 Nov 13, 2018	BUY	$23.55 - $30.1 $86,664 - $110,768	3,680 Added 4.59%	83,810 $2.08 Million
Q2 2018 Aug 10, 2018	BUY	$27.45 - $33.35 $592,920 - $720,360	21,600 Added 36.9%	80,130 $2.2 Million
Q1 2018 May 09, 2018	BUY	$29.15 - $37.4 $590,141 - $757,163	20,245 Added 52.88%	58,530 $1.8 Million
Q4 2017 Feb 14, 2018	SELL	$24.55 - $36.3 $294,600 - $435,599	-12,000 Reduced 23.86%	38,285 $0
Q3 2017 Nov 13, 2017	BUY	$22.55 - $28.1 $1.13 Million - $1.41 Million	50,285	50,285 $1.39 Million

Others Institutions Holding RVNC

# of Institutions

233

Shares Held

82.1M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Revance Therapeutics, Inc. Transaction History